Schioppo et al. found increased serum levels of NTproBNP in 27/87 (31%) patients with SSc with known cardiac dysfunction, with values significantly higher when compared to patients without cardiac dysfunction (p = 0.0003; 95% C.I.: 57–232) [23]. This evidence concerns the gene NPPB and systemic sclerosis.